Stockreport

Is Stronger Guidance and CHOPIN Data Changing the Investment Case for Delcath Systems (DCTH)? [Yahoo! Finance]

Delcath Systems, Inc.  (DCTH) 
US:NASDAQ Investor Relations: delcath.com/investors
PDF million from its CHEMOSAT and HEPZATO KIT products, as well as positive results from the CHOPIN Phase 2 trial showing significantly improved progression-free survival fo [Read more]